Keytruda is set to be the top selling drug worldwide in 2026 with $24.9bn sales, a forecast almost double its closest rival. 
Download your free copy of the new EvaluatePharma World Preview 2020 to find out more
https://t.co/i6IkIpUSwq
#oncology $MRK https://t.co/AniTyejooE